명의 월스트리트 애널리스트에 따르면, THC Therapeutics Inc의 매출 추정치는 $에서 $까지입니다.
THC Therapeutics Inc의 수익 품질 점수는 얼마인가요?
THC Therapeutics Inc의 수익 품질 점수는 B+/54.79484입니다. 이 점수는 수익성, 성장, 현금 창출 및 자본 배분, 레버리지의 네 가지 차원을 기반으로 합니다.
THC Therapeutics Inc는 언제 수익을 보고하나요?
THC Therapeutics Inc의 다음 수익 보고서는 2026-02-12에 발표될 예정입니다.
THC Therapeutics Inc의 예상 수익은 얼마인가요?
월스트리트 애널리스트에 따르면 THC Therapeutics Inc의 예상 수익은 $입니다.
THC Therapeutics Inc은 수익 기대치를 충족했나요?
THC Therapeutics Inc의 최근 수익은 $로, 기대치를 .
주요 통계
이전 종가
$0.0009
시가
$0.0001
일일 범위
$0.0001 - $0.0009
52주 범위
$0.0001 - $0.1
거래량
227.6K
평균 거래량
13.5K
배당수익률
--
EPS(TTM)
-0.02
시가총액
$36.2K
THCT란 무엇인가요?
THC Therapeutics, Inc. engages in developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The company is headquartered in Las Vegas, Nevada and currently employs 1 full-time employees. The company went IPO on 2007-12-07. The firm is focused on developing a sanitizing herb dryer, the dHydronator, with multiple design, function, and usage patents. The dHydronator product is specifically designed for the drying and sanitizing (i.e., reducing the bacterial count by using ultraviolet light) of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The dHydronator can reduce the moisture content of cannabis to 10-15% in only 10-14 hours. The company can also reduce the bacterial count of cannabis during the drying process. The firm also operates a portfolio of companies in genetics, cultivation, extraction, and distribution as well as specialty real estate and nutrients for commercial and hobby cannabis growers. These companies consist of Jefferson Soul, Kalix, NPK Industries, Harvest Food for Life, Shasta Properties Management, and Blue Sky Investments.